Total no | AHCYL1 low no (%) | AHCYL1 high no (%) | p value | |
---|---|---|---|---|
20 | 5 (25%) | 15 (75%) | ||
Age (years ± SD) | 64.9 (9.9) | 67.3 (8.2) | 64.0 (10.6) | 0.539a |
Gender (%) | 0.038*b | |||
Male | 11 (55%) | 5 (100%) | 6 (40%) | |
Female | 9 (45%) | 0 (0%) | 9 (60%) | – |
Follow-up time (median-IQR) | 452 (30–1976) | 379(365–833) | 1694 (1246–2535) | 0.098c |
Tumor size (mm ± SD) | 29.5 (16.5) | 24.2 (9.9) | 31.3 (18.1) | 0.417a |
Pleural infiltration (%) | 8 (40%) | 2 (40%) | 6 (40%) | 1.000b |
Histologic grade (3 vs. 1–2) | 9 (45%) | 3 (60%) | 6 (40%) | 0.396b |
UICC TNM Stage (II–III) | 7 (35%) | 1 (20%) | 6 (40%) | 0.406b |
Ki67 (% median-IQR) | 15 (5–35) | 60 (30–70) | 5 (5–17) | 0.004*c |